MAPT and Alzheimer disease: Furthermore, [18F]MK-6240 displays high affinity to PHF-tau (in the subnanomolar concentration range), which may have practical implications for the detection of tau inclusions during the early stages of AD and quantification of subtle changes in tau burden over time [7].